人工智能在炎症性肠病中的应用
Jiaxuan Ran1, Mingxia Zhou, Hongtao Wen
1Department of Gastroenterology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China.
概括
人工智能 (AI) 正通过分析复杂的数据来获得更好的见解来彻底改变炎症性肠病 (IBD) 研究. 这项技术有助于诊断,患者分层和个性化治疗计划,改善结果并降低成本.
科学领域:
- 胃肠道学和计算生物学
- 专注于人工智能和炎症性肠病研究的交集.
背景情况:
- 炎症性肠病 (IBD) 是一种复杂的胃肠道疾病,有多因素的原因.
- 最近的奥米克和网络技术的进步加速了IBD研究.
- 人工智能 (AI) 为解释大型生物数据集提供了强大的工具.
研究的目的:
- 审查人工智能的原则及其在IBD研究中的当前应用.
- 探索AI在推进IBD有针对性的治疗策略方面的潜力.
- 突出AI在改善胃肠病学诊断准确性和患者管理方面的作用.
主要方法:
- 关于人工智能在胃肠病和IBD中的应用现有文献的综述.
- 分析AI在内镜分析中的实用性,包括癌症和息肉检测.
- 检查AI在患者分层和治疗反应预测中的作用.
主要成果:
- 人工智能增强了IBD研究中复杂数据集的解释.
- 人工智能有助于结直肠癌,多和炎症性病变的内镜诊断.
- 人工智能支持个性化的患者管理,包括预测疾病进展和治疗反应.
结论:
- 在IBD研究中的AI整合加速了可操作见解的发现.
- 人工智能驱动的方法有望优化治疗策略并改善患者的治疗结果.
- 未来的IBD管理可能将涉及对个性化医疗的显著AI贡献.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
236
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
236
Inflammatory Bowel Disease IV: Pharmacological Management
80
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
80
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
97
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
97
Inflammatory Bowel Disease II: Crohn's Disease
127
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
127
Inflammatory Bowel Disease I: Ulcerative Colitis
94
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
94
Inflammatory Bowel Disease V: Surgical Management
59
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
59


